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Nucleotide insertion/deletion polymorphisms (indels) in ApoE gene were precisely genotyped
using artificial ribonucleases and MALDI-TOF MS. The RNA fragments for MS analysis were
prepared by treating RNA specimens with our artificial ribonucleases, which consist of LuCl3
(molecular scissors) and oligonucleotides bearing two acridine groups (RNA-activator for
site-selective scission). RNA scission by Lu(III) ion always occurred at the phosphodiester
linkages in front of the two acridines, even when the RNA specimens involved consecutive
cytidine sequences of different lengths. Thus, even complicated mixtures of these indel
specimens were completely genotyped by using only one acridine-bearing oligonucleotide and
by subjecting the reaction mixture to single MS measurement. Moreover, single nucleotide
polymorphism (SNP) in the consecutive sequences could be genotyped simultaneously with
the indels. (J Am Soc Mass Spectrom 2006, 17, 3–8) © 2005 American Society for Mass
SpectrometryCompletion of the human genome project hasopened a new era in medicine, pharmacogenom-ics, and biotechnology. Through systematic and
detailed analysis of genomic information, various
markers for hereditary characteristics of individuals
have been found [1–3]. Single nucleotide polymor-
phisms (SNPs) have already been widely used as a
powerful tool for a variety of medical and genetic
applications. Another important polymorphism is the
insertion of one (or more) nucleotide to genes or its
deletion (indels). One of the promising applications of
indel genotyping is to detect microsatellite instability
(MSI), which represents length variation of short repet-
itive sequences and is primarily derived from defi-
ciency in the mismatch repair system [4 –10]. In hered-
itary nonpolyposis colorectal cancer (HNPCC), for
example, length variations in growth regulatory genes
are being used as diagnostic markers [11–12].
To date, indels have been genotyped mostly by gel
electrophoresis [13–15]. However, this method some-
times suffers from compression artifacts attributable to
the secondary structures of specimens. On the other
hand, a number of methods for SNP genotyping have
been already proposed. However, few of them are
completely satisfactory with respect to reliability, cost,
and/or sensitivity. In addition, they are not easily
applicable to indel genotyping. In most of the SNP
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doi:10.1016/j.jasms.2005.08.016genotyping methods, probes (usually DNA) hybridize
to the specimen and distinguish matching duplex from
mismatching duplex. Indels in consecutive sequences
cannot be clearly genotyped by such methods, since
partial hybridization often occurs in the repetitive se-
quences. One of a few successful applications is based
on primer extension method [16]. However, it requires
specific combination of dNTP and ddNTP depending
on the sequence investigated. Thus, simultaneous geno-
typing of SNPs and indels has not yet been successful,
although it should provide comprehensive information
on hereditary characteristics that cannot be obtained
when only SNPs are genotyped.
Matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOF MS) has been
attracting interest as eminent means of SNPs genotyp-
ing [17–20]. By determining the mass of relevant DNA
fragments from the genome, accurate results are obtain-
able in high throughput with relatively small cost.
When RNA fragments from transcripts are used as
specimen, the sensitivity of MS analysis can be further
promoted since the ionized fragments formed by laser
irradiation in the instrument are stabilized by the 2=-OH
groups [21–26]. In the pioneering work by Krebs et al.,
RNA fragments for SNP genotyping were produced by
cutting transcripts with a ribozyme moiety introduced
therein [27]. Use of naturally occurring G-specific ribo-
nuclease, in place of ribozyme, was also attempted [28].
Only recently, we used an artificial RNA cutter to
prepare RNA fragments for SNPs genotyping by
MALDI-TOF MS [29]. By combining Lu(III) ion (molec-
ular scissors) and oligonucleotide bearing two acridines
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scripts were selectively cut at two designated positions
(see Scheme 1, where the gray ellipsoids show the
acridines), and predetermined short RNA fragments
containing the SNP site were selectively clipped out of
the transcripts. The nucleotides at the SNP site were
unambiguously determined by analyzing the mass
number of the RNA clippings. Advantageously, these
artificial cutters require no specific sequence at the
scission site [30]. These results indicated to us that these
cutters are promising for genotyping of indels, which
are often observed in highly repetitive sequences (for
example, RNACCC in Figure 1 involves C12 sequence). It
is usually difficult to cut such sites selectively by using
other RNA cutters. In this paper, various RNA clip-
pings involving indels are successfully prepared by
using the artificial RNA cutters, and clearly genotyped
by MALDI-TOF MS. Significantly, only one RNA-acti-
vator is necessary to genotype a mixture of various
types of indels, although the corresponding scission
sites in RNA specimens are at different distances from
each other. Furthermore, both indels and SNPs are
simultaneously genotyped even when they are located
nearby in the gene. As an example, RNA coding ApoE
gene, which is associated with Altzheimer’s disease and




RNA specimens and RNA-activators (acridine-DNA
conjugates) in Figure 1 were prepared on an ABI 394
DNA synthesizer in 1 mole scale by using the phos-
phoramidite monomers from Glen Research Co. (Ster-
ling, VA), and purified by 15% denaturing PAGE and
RP-HPLC. All the oligonucleotides were fully charac-
terized by MALDI-TOF MS. Their base compositions
were further confirmed by HPLC analyses on the di-
gests obtained with snake venom phosphodiesterase
and alkaline phosphatase. Water was deionized by
Millipore Water Purification System (Billerica, MA) and
sterilized by an autoclave immediately before use.Scheme 1. Outline of the present genotyping.Commercially obtainable LuCl3 (from Nacalai Tesque,
Kyoto, Japan) was used without further purification.
Genotyping by MALDI-TOF MS
A typical procedure is as follows. In 10 l of 10 mM
Tris-HCl buffer (pH 7.5) containing NaCl (200 mM),
RNA specimen (40 pmole) and the acridine-DNA con-
jugate (100 pmole) were dissolved. The mixture was
heated to 90 °C (for 1 min) and slowly cooled down to
room temperature. Aqueous solution of LuCl3 was
added to the mixture (the final concentration, 150 M),
and the reaction was achieved at 25 °C.
After 24 h, the mixture was directly desalted by
micropipette tip containing C18 media at the end (Zip-
Tip from Millipore), and added to a matrix solution
containing saturated 3-hydroxypicolinic acid, 0.5 M
diammonium hydrogen citrate, and acetonitrile (30%).
Mass analyses were carried out on a Bruker AutoFLEX
(Bruker Daltonics Inc., Billerica, MA) mass spectrome-
ter in positive ion mode. The amount of RNA on one
spot of the mass plate was about 6 pmole. Experimental
error in the mass number is around 0.05%. The reaction
mixtures were also analyzed on 20% denaturing PAGE
with Fuji Film FLA-3000G (Minamiashigara, Japan)
fluorescent imaging analyzer.
In Vitro Transcription of Genomic RNA Substrate
The DNA fragment of human apoE 3 gene (nucleotide
5171-5249) was amplified by PCR with an SP6 promoter-
appended primer. The structure was confirmed by DNA
sequencing. The required 79-mer RNA was prepared by
in vitro transcriptionwith a RiboMAX SP6 RNA transcrip-
tion kit (Promega,Madison,WI), andwas purifiedwith an
RNeasy mini kit (Qiagen, Hilden, Germany). The full
sequence of this RNA is as follows: 5=-cccaucucca cacacac-
cac Ccccccccca aauuaauccu agugguaugc gccuguaguc
ucagcuacug gaaaggcug-3= (the upper case C indicates the
multiallelic site at nucleotide 5229).
Results and Discussions
Genotyping of Indels and SNPs
Using the Artificial RNA Cutter
RNA specimens that correspond to the antisense
Figure 1. Structures of RNA specimens and RNA-activators
(acridine-DNA conjugates). The 5=-ends of RNA specimens are
labeled with fluorescein (FAM) for PAGE analysis. The selective
scission sites are indicated by the arrows.strand of human ApoE gene from nucleotide (nt) 5208
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in this region is a multiallelic site, and the following
five variants are known; C-allele (RNAC), one and
two C insertion (RNACC and RNACCC, respectively),
C deletion (RNAdel), and A-allele (RNAA ) (Figure 1).
This site adjoins C8 tract, and the lengths of consec-
utive C sequence are, accordingly, nine for RNAdel,
ten for RNAC, and eleven for RNACC. These RNA
samples were treated with LuCl3 in the presence of
Acr-DNA(1) which is complementary with RNACCC
and has 6-chloro-2-methoxyacridine in front of C5232
and another 6-chloro-2-methoxyacridine in front of
A5215. In the heteroduplex between RNACCC and
Acr-DNA(1), all the ribonucleotides in RNACCC form
Watson-Crick base pairs except C5232 and A5215.
The 5=-sides of these two ribonucleotides are the
target sites for the site-selective scission by Lu(III)
[29]. The portion involving either indel or SNP exists
between these two scission sites. As shown in Chart V
of Figure 2a, the expected RNA fragment (C5232-
U5216) was successfully formed after the cleavage
reaction with Lu(III), providing a concrete genotyp-
ing result. The observed m/z value of the scission
fragment is 5909.6, which are in fair agreement with
the theoretical value 5911.8 for the fragment bearing
both 5=-OH and 3=- (or 2=-)monophosphate. The reac-
Figure 2. MALDI-TOF MS spectra for the prod
(III) RNAA, (IV) RNACC, and (V) RNACCC by Lu
(b) acridine-DNA(2). The mass analysis was perf
the RNA scission: pH 7.5 and 25 °C for 24 h; [RN 0
[Lu(III)]  150 M; [NaCl]  200 mM.tion proceeds as transesterification at the two target
sites, followed by hydrolysis of the cyclic monophos-
phates [30].
When RNAdel, RNAC, and RNACC form duplexes
with Acr-DNA(1), three, two, and one G residue(s) in
Acr-DNA(1) are kept unpaired, respectively. Even
under these conditions, the RNA scission selectively
occurred at the two target sites in front of the two
acridines and, thus, the scission fragments from
RNAdel, RNAC, and RNACC were shorter than that
from RNACCC by three, two, and one C residue(s),
respectively (Charts I, II, and IV in Figure 2a). The
observed m/z values (4996.4 for RNAdel, 5300.1 for
RNAC, and 5606.1 for RNACC) are in fair agreement
with the theoretical values (4996.7, 5301.7, and
5606.8). As shown in Chart III, RNAA was also
selectively hydrolyzed at the designated two sites,
although a G-A mismatch was formed in the corre-
sponding heteroduplex with the Acr-DNA(1) (ob-
served m/z  5324.7 and theoretical m/z  5325.7).
The tandem site-selective scission was further con-
firmed by PAGE analysis of the reaction mixture
(data not shown). Accordingly, all types of variations
(indels and SNPs) could be genotyped by using only
one RNA-activator.
f site-selective scission of (I) RNAdel, (II) RNAC,
in the presence of either (a) acridine-DNA(1) or
d in positive ion mode. Reaction conditions for
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In DNA-mismatch repair-deficient cells, repetitive se-
quences called microsatellite are particularly suscepti-
ble to DNA polymerase slippage and strand misalign-
ment during DNA replication. This results in a long
variation of the microsatellite (MSI), which is the hall-
mark of some cancers like HNPCC. Because of such
origin of MSI, specimens from cells showing MSI are
often obtained as mixtures of RNA of various lengths.
Accordingly, the following four samples were analyzed
in Figure 3a: (I) RNAC (C-allele RNA)  RNAdel (one-
base deletion), (II) RNAC RNACC (insertion of one C),
(III) RNAC  RNAdel  RNACC, and (IV) RNAC 
RNAdel  RNACC  RNACCC (insertion of two C). For
all the mixtures, acridine-DNA(1) was used as RNA-
activator for the Lu(III)-induced site-selective scission.
In the MS spectra, the signal from each of the RNA
fragments was completely separated from each other,
and clear-cut genotyping was accomplished.
Genotyping of SNPs Near Indels
The nucleotide at the SNP site in one chromosome can
be different from the one in the counterpart chromo-
Figure 3. Simultaneous genotyping of various
(a) Acr-DNA(1) or (b) Acr-DNA(2): (I) RNAC  R
RNAdel  RNACC (1:1:1), and (IV) RNAC 
conditions for the RNA scission are the same as
 4.0 M.some (heterozygote). In some cases, this polymorphismcan be further accompanied by indels. To confirm
the applicability of the present method to these still
more complicated systems, the following mixtures were
genotyped by using acridine-DNA(1) (I) RNAC (C-allele
RNA)  RNAA (A-allele RNA), (II) RNAC  RNAA 
RNAdel (III) RNAC  RNAA  RNACC, and (IV) RNAC
 RNAA  RNAdel RNACC. As shown in Figure 4, the
expected signal was clearly detected for each of the
RNAs, and all of them were explicitly separated from
each other. Thus, even in these complicated mixtures,
all the polymorphisms can be simultaneously and
clearly genotyped by using only one RNA-activator
together with LuCl3.
Design of the Site-Selective RNA-Activator
for Genotyping of Indels and SNPs
The results of site-selective RNA scission using another
RNA-activator, acridine-DNA(2), are presented in Fig-
ure 2b. This DNA conjugate is complementary with
RNAC and has two acridines in front of C5232 and
A5208. In contrast with the case of Acr-DNA(1), several
ribonucleotides in the RNA specimens remain unpaired
when they form heteroduplexes with this DNA conju-
gate. Thus, two C residues in RNACCC and one C
of indels using Lu(III) in the presence of either
el (1:1), (II) RNAC  RNACC (1:1), (III) RNAC 
del  RNACC  RNACCC (1:1:1:1). Reaction
gure 2 except for [total concentration of RNA]0types
NAd
 RNA
 in Firesidue in RNACC are unpaired and form bulge-struc-
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in RNAA are unpaired and one A residue is a mismatch
to the counterpart G in Acr-DNA(2). Even under these
conditions, sufficient amounts of desired RNA frag-
ments were obtained and precise genotyping by MS
analysis was successful. In the heteroduplexes, the
phosphodiester linkages near the unpaired ribonucle-
otides are satisfactorily protected from the subsequent
digestion by Lu(III) (otherwise, they should be
promptly hydrolyzed by this metal ion since a single-
stranded RNA is far more susceptible to the hydrolysis)
[32]. Accordingly, simultaneous genotyping of various
types of indels from the mixtures was also successful
with the use of Acr-DNA(2) (see Figure 3b).
Genotyping of RNA specimens correspond to the
sense strand of ApoE, which involve consecutive G
residues, was also possible in a similar manner (data
not shown). Both the strands in the gene (sense and
antisense strands) can be chosen as RNA specimens.
Apparently, design of acridine-DNA conjugates as
site-selective RNA-activator can be very versatile (they
also protect the scission fragments from subsequent
Lu(III)-induced digestion). The present RNA scission
requires no specific sequence at the scission site and,
thus, can be achieved at any desired site [29, 30].
Distinction of C and U (mass number difference  1
unit) can be avoided by choosing a complementary
strand as the specimen and to distinguish G and A that
Figure 4. Simultaneous genotyping of indels and SNPs using
Lu(III) in the presence of Acr-DNA(1): (I) RNAC  RNAA (1:1), (II)
RNAC  RNAA  RNAdel (1:1:1), (III) RNAC  RNAA  RNACC
(1:1:1), and (IV) RNAC  RNAA  RNAdel  RNACC (1:1:1:1).
Reaction conditions for the RNA scission are the same as in Figure 3.differ by 16 units. This is a significant advantage of thesystem (ribozymes usually require specific sequences at
the scission sites) [33].
Genotyping of Human Genomic Sample
A 79-mer RNA transcript of apoE 3 gene (nt 5171-5249)
was prepared from the blood of a patient, and was
treated by LuCl3 in the presence of Acr-DNA
(1) (de-
tailed experimental procedures are presented in the
Experimental section). As shown in Figure 5, this
genomic RNA was also successfully cut at the two
designated sites, and a MS signal was observed atm/z
5302.9. It can be concluded that this patient is C-allele
homozygote, and there exists neither deletion nor inser-
tion in this region of the gene (the theoretical m/z 
5301.7). Of course, this result is completely consistent
with the conclusion from the conventional DNA se-
quencing experiments.
Conclusions
This paper presents a reliable and economical method
for genotyping of indels. In the presence of oligonucle-
otide bearing two acridines (RNA-activator), RNA tran-
scripts are treated with LuCl3, and the resultant frag-
ments are analyzed by MALDI-TOF MS. Since the RNA
scission by the present cutters always occurs in front of
the acridines and requires no specific sequence at the
scission site, the genotyping is successful irrespective of
the position of indels and the number of inserted/
deleted nucleotides therein. Indels in highly consecu-
tive sequences are also genotyped by this method,
although site-selective scission around (or in) these
sequences is quite difficult with any other reagents
hitherto proposed. It is also noteworthy that indels
cannot be easily detected by conventional DNA chips.
The RNA specimens in Figure 1, for example, have
Figure 5. Genotyping of human apoE gene by MALDI-TOF MS;
the 79-mer transcript from the gene (from nt 5171 to 5249) was
treated with Lu(III) in the presence of Acr-DNA(1). The scission
conditions are the same as in Figure 3 except for [Lu(III)]  300 M.consecutive C sequences so that the melting tempera-
8 SASAYAMA ET AL. J Am Soc Mass Spectrom 2006, 17, 3–8tures of their duplexes with the complementary coun-
terparts (having consecutive G) are very high and are
hardly dependent on mismatch and/or bulge structure
between them.
Even when SNPs exist near or in indels, they can
both be simultaneously genotyped by the present
method. Accordingly, the hereditary characteristics of
individuals involving a variety of indels and SNPs can
be easily analyzed without any ambiguity. Accumula-
tion of these comprehensive data should make genome
science still more fruitful.
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